Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Polonelli

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Scandinavian Journal of Immunology|January 1, 1993
Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activityL Polonelli, R Lorenzini, F De Bernardis, et al.
Molecular Medicine (Cambridge, Mass.)|September 21, 2000
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocciS Conti, W Magliani, S Arseni, et al.
Nature Biotechnology|February 1, 1997
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activityW Magliani, S Conti, F de Bernardis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1996
Human natural yeast killer toxin-like candidacidal antibodiesL Polonelli, F De Bernadis, S Conti, et al.
Nature Medicine|June 12, 1998
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypesW Magliani, L Polonelli, S Conti, et al.
Oral Microbiology and Immunology|June 10, 2005
In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungalsM Manfredi, M J McCullough, S Conti, et al.
Medical Mycology|February 13, 1999
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?A Casadevall, A Cassone, F Bistoni, et al.
Reviews of Infectious Diseases|May 1, 1988
Invasive Fusarium solani infections in patients with acute leukemiaM Venditti, A Micozzi, G Gentile, et al.
Oral Microbiology and Immunology|April 22, 2006
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitusM Manfredi, M J McCullough, L Polonelli, et al.
Current Molecular Medicine|June 28, 2005
Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicansM J Omaetxebarría, M D Moragues, N Elguezabal, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Scandinavian Journal of Immunology|January 1, 1993
Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activityL Polonelli, R Lorenzini, F De Bernardis, et al.
Molecular Medicine (Cambridge, Mass.)|September 21, 2000
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocciS Conti, W Magliani, S Arseni, et al.
Nature Biotechnology|February 1, 1997
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activityW Magliani, S Conti, F de Bernardis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1996
Human natural yeast killer toxin-like candidacidal antibodiesL Polonelli, F De Bernadis, S Conti, et al.
Nature Medicine|June 12, 1998
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypesW Magliani, L Polonelli, S Conti, et al.
Oral Microbiology and Immunology|June 10, 2005
In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungalsM Manfredi, M J McCullough, S Conti, et al.
Medical Mycology|February 13, 1999
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute?A Casadevall, A Cassone, F Bistoni, et al.
Reviews of Infectious Diseases|May 1, 1988
Invasive Fusarium solani infections in patients with acute leukemiaM Venditti, A Micozzi, G Gentile, et al.
Oral Microbiology and Immunology|April 22, 2006
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitusM Manfredi, M J McCullough, L Polonelli, et al.
Current Molecular Medicine|June 28, 2005
Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicansM J Omaetxebarría, M D Moragues, N Elguezabal, et al.
Pageof 12